REMSleep Holdings, Inc. Shareholder Update
REMSleep Holdings (OTCQB: RMSL) announces a delay in the launch of their Deltawave nasal pillows mask, now projected for end of January 2025. The delay is attributed to FDA regulatory compliance requirements and supplier scheduling constraints, including coordination with mold, packaging, and material manufacturers. The company has secured two major distributors awaiting product evaluation and is upgrading its website with e-commerce capabilities. Despite the setbacks, REMSleep remains committed to launching the product and continues new product development with molds in the pipeline.
REMSleep Holdings (OTCQB: RMSL) annuncia un rinvio nel lancio della loro maschera nasale Deltawave, ora previsto per la fine di gennaio 2025. Il rinvio è attribuito a requisiti di conformità normativa della FDA e a vincoli di programmazione dei fornitori, inclusa la coordinazione con i produttori di stampi, imballaggi e materiali. L'azienda ha assicurato due importanti distributori in attesa della valutazione del prodotto e sta aggiornando il proprio sito web con funzionalità di e-commerce. Nonostante i ritardi, REMSleep rimane impegnata nel lancio del prodotto e continua lo sviluppo di nuovi prodotti con stampi in lavorazione.
REMSleep Holdings (OTCQB: RMSL) anuncia un retraso en el lanzamiento de su máscara de almohadillas nasales Deltawave, ahora proyectado para finales de enero de 2025. El retraso se atribuye a los requisitos de cumplimiento regulatorio de la FDA y a las limitaciones de programación de los proveedores, incluida la coordinación con fabricantes de moldes, empaques y materiales. La empresa ha asegurado dos importantes distribuidores que esperan la evaluación del producto y está mejorando su sitio web con capacidades de comercio electrónico. A pesar de los contratiempos, REMSleep sigue comprometida a lanzar el producto y continúa con el desarrollo de nuevos productos con moldes en proceso.
REMSleep Holdings (OTCQB: RMSL)는 Deltawave 코실 마스크 출시가 2025년 1월 말로 연기된다고 발표했습니다. 이번 연기는 FDA 규제 준수 요건과 공급업체 일정 문제로 인한 것으로, 금형, 포장 및 재료 제조업체와의 조정이 포함됩니다. 회사는 제품 평가를 기다리고 있는 두 개의 주요 유통업체와 계약을 체결하였으며, 전자상거래 기능이 포함된 웹사이트를 업그레이드하고 있습니다. 지연에도 불구하고, REMSleep은 제품 출시를 위해 최선을 다하고 있으며, 현재 진행 중인 금형으로 새로운 제품 개발을 계속하고 있습니다.
REMSleep Holdings (OTCQB: RMSL) annonce un retard dans le lancement de son masque nasal Deltawave, désormais prévu pour la fin janvier 2025. Ce retard est attribué aux exigences de conformité réglementaire de la FDA et à des contraintes de programmation des fournisseurs, notamment la coordination avec les fabricants de moules, d'emballages et de matériaux. L'entreprise a sécurisé deux grands distributeurs en attente de l'évaluation du produit et améliore son site Web avec des capacités de commerce électronique. Malgré ces retards, REMSleep reste déterminée à lancer le produit et continue le développement de nouveaux produits avec des moules en préparation.
REMSleep Holdings (OTCQB: RMSL) gibt bekannt, dass die Einführung ihrer Deltawave Nasenpolster-Maske auf Ende Januar 2025 verschoben wird. Die Verzögerung wird auf die Anforderungen der FDA zur Einhaltung von Vorschriften und auf Terminengpässe der Lieferanten zurückgeführt, einschließlich der Koordination mit Herstellern von Formen, Verpackungen und Materialien. Das Unternehmen hat zwei wichtige Distributoren gesichert, die auf die Produktbewertung warten, und verbessert seine Website mit E-Commerce-Funktionen. Trotz der Rückschläge bleibt REMSleep engagiert, das Produkt auf den Markt zu bringen und arbeitet weiterhin an der Entwicklung neuer Produkte mit laufenden Formen.
- Secured two major distributors pending product evaluation
- Website upgrade in progress with e-commerce integration
- New product development ongoing with additional molds in pipeline
- Product launch delayed until January 2025
- Supply chain constraints affecting production timeline
- Extended delay of over two years in product commercialization
CLEARWATER, Fla., Nov. 15, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL): To all stockholders, this is an update as to the status of the launch of the Deltawave product to the marketplace.
Investors are anxious for Deltawave to be introduced to market. REMSleep is anxious for the Deltawave to be introduced to sleep apnea sufferers. We want to thank all our stockholders for the continued support, loyalty and trust. We all know how frustrating this has been over the last two years or more, and admittedly most start-ups would have thrown in the towel.
REMSleep is a small start-up company. Yet, we are in it to win it and have no intention of stopping until we launch this to the marketplace.
We wanted to inform all that we will, however, experience an additional delay introducing the new Deltawave nasal pillows mask to market. REMSleep has no control over this delay as we wait for product arrival.
We project we will be introducing the Deltawave mask to market the end of January 2025. This decision was made through advice from our regulatory consultant to assure REMSleep will be fully compliant to FDA regulations, among other critical considerations.
Additionally, we must fit into the schedules of our suppliers.
This includes mold manufacturers, packaging manufacturers and material manufacturers. For example, the specialized medical grade silicone used in our products has a strictly monitored shelf life and must be procured in a timely manner that matches production schedules.
For those who have been questioning the delays and disagree with the momentum and the timelines we have been navigating, we believe that we have been responsible and prudent based on the cadence of approvals presented. As much as we would have liked to pull the trigger for mass production earlier, we had to hold on many different occasions to be assured we were investing our money wisely as timelines and regulations continued to change.
We regret these delays, but we take comfort in knowing that the Deltawave is an unequivocal super star which will make a huge impact on the market. We are confident every distributor on the map will want to offer the Deltawave and next generation REMSleep masks in the future.
Here are some updates on major workstreams to date:
- We have secured two major distributors who are waiting for completed products to be evaluated.
- We are currently upgrading our website to better represent our current and new product lines as well as integrating up to date e-commerce capabilities.
- New product development continues with molds in the pipeline in anticipation of a smooth 510K for new product development based on lessons learned from the past.
We greatly appreciate those who have “hung in there” with us through these tumultuous years. One thing should be clear to our investors, we are all determined to get the Deltawave as well as other new products into the marketplace.
Contact:
Tom Wood
912-590-2001
twood@remsleep.com
FAQ
When will REMSleep Holdings (RMSL) launch the Deltawave mask?
What is causing the delay in REMSleep's (RMSL) Deltawave product launch?
How many distributors has REMSleep Holdings (RMSL) secured for Deltawave?
